P1303: POTENTIATING ANTI-CD20 MONOCLONAL ANTIBODY THERAPY BY TARGETING COMPLEMENT C3 ACTIVATION FRAGMENTS COVALENTLY DEPOSITED ON LYMPHOMA CELLS

• A. Wiestner,
• S. Baskar,
• H. Peng,
• E. Gaglione,
• M. Lindorfer,
• R. Taylor,
• C. Rader

Affiliations

A. Wiestner

1 Hematology Branch, NHLBI, NIH, Bethesda

S. Baskar

1 Hematology Branch, NHLBI, NIH, Bethesda

H. Peng

2 Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter

E. Gaglione

1 Hematology Branch, NHLBI, NIH, Bethesda

M. Lindorfer

3 Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, United States of America

R. Taylor

3 Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, United States of America

C. Rader

2 Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter